• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文学位 >Anticancer pharmacology of natural and semi-synthetic lignans from Larrea tridentata (Moc and Sess) cov. (Zygophyllaceae).
【24h】

Anticancer pharmacology of natural and semi-synthetic lignans from Larrea tridentata (Moc and Sess) cov. (Zygophyllaceae).

机译：天然和半合成木脂素从Larrea tridentata（Moc和Sess）cov获得的抗癌药理作用。 （霸王龙）。

获取原文
获取原文并翻译 | 示例
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

The objective of this dissertation was to isolate, identify, modify, and pharmacologically characterize lignans from Larrea tridentata (Zygophyllaceae) which possessed antitumor activity.; Seven lignans including the novel 3,4′-dihydroxy-3 ′,4-dimethoxy-6,7′-cyclolignan ( 3), and one flavanone were isolated. Although 1-(3-hydroxy-4-methoxyphenyl)-4-(3-methoxy-4-acetoxyphenyl)2,3-dimethylbutane (1) was previously reported, the spectroscopic data is reported here for the first time.; Eight acyl and alkyl derivatives of nordihydroguaiaretic acid (NDGA) were prepared to determine the effect of additions to the catechol hydroxyl on tumor cell cytotoxicity.; All of the compounds were assessed for their cytotoxicity in human tumor cell lines. NDGA and compounds 1–14 had IC50 values ranging from 6–60 μM in all cell lines. Compounds 2 and 15 were active only against human breast cancer cells. There appeared to be a positive correlation between the number of O-methyl substitutions on the NDGA molecule and potency against breast cancer cells. NDGA and tetra-O-methylnordihydroguaiaretic acid (M4N) were chosen for further study based on cytotoxicity results and compound availability. Both compounds inhibited DNA synthesis, but only M4N demonstrated antitumor activity in vivo. M4N induced cell cycle arrest in the G0/G1 and the G2/M phases and induced apoptosis in melanoma cells. Myeloma cells with decreased topoisomerase IIα levels exhibited increased sensitivity to M4N, although M4N inhibited neither topoisomerase Ila or topoisomerase I in a cell-free system. In cells with decreased topoisomerase IIβ levels, the increased sensitivity to M4N was ablated. This suggests topoisomerase IIβ partially mediates M4N cytotoxicity.; NDGA was hepatotoxic both in vitro and in vivo (LD50 = 75 mg/kg (i.p.) in the mouse). M4N was non-toxic in vivo and did not alter hepatic enzymes. This demonstrates the importance of the catechol hydroxyls in causing hepatotoxicity.; NDGA (i.v.) exhibited two-compartment pharmacokinetics with a distribution half-life of 30 min and a terminal half-life of 135 min in mice. The peak plasma concentration was 14.7 μg/mL and the clearance was 201.9 mL/(min*kg).; Overall, several new compounds were identified from L. tridentata that have an improved therapeutic index, compared with NDGA, against human cancer cells. This growth inhibition may involve topoisomerase II inhibition leading to cell cycle arrest and impaired DNA synthesis.
机译：本文的目的是从具有抗肿瘤活性的（Zygophyllaceae）中分离，鉴定，修饰和药理鉴定木脂素。七个木脂素，包括新型3,4 ' -dihydroxy-3 '，4-二甲氧基-6,7 ' -cyclolignan（ 3 ），并分离出一种黄烷酮。尽管先前曾报道过1-（3-羟基-4-甲氧基苯基）-4-（3-甲氧基-4-乙酰氧基苯基）2,3-二甲基丁烷（ 1 ），但此处报道的光谱数据为第一次。;制备了八种去氢二氢愈创木酸的酸和烷基衍生物（NDGA），以确定儿茶酚羟基添加物对肿瘤细胞毒性的影响。评估所有化合物在人肿瘤细胞系中的细胞毒性。 NDGA和化合物 1-14 在所有细胞系中的IC 50 值范围均为6-60μM。化合物 2 和 15 仅对人乳腺癌细胞具有活性。在NDGA分子上的 O -甲基取代的数目与对乳腺癌细胞的效力之间似乎存在正相关。根据细胞毒性结果和化合物的可获得性，选择了NDGA和四-斜体-O-斜体-甲基去甲二氢愈创木酸（M 4 N）进行进一步研究。两种化合物均抑制DNA合成，但只有M 4 N在体内显示出抗肿瘤活性。 M 4 N诱导的细胞周期阻滞于G 0 / G 1 和G 2 / M期诱导黑色素瘤细胞凋亡。拓扑异构酶IIα水平降低的骨髓瘤细胞对M 4 N的敏感性增强，尽管M 4 N在无细胞系统中均不抑制拓扑异构酶Ila或拓扑异构酶I。在拓扑异构酶IIβ水平降低的细胞中，对M 4 N的敏感性增加被消除。这表明拓扑异构酶IIβ部分介导M 4 N的细胞毒性。 NDGA在体外和体外都具有肝毒性（小鼠体内的LD 50 = 75 mg / kg（i.p.））。 M 4 N在体内是无毒的，不会改变肝酶。这证明了儿茶酚羟基在引起肝毒性中的重要性。 NDGA（i.v.）在小鼠中表现出两室药代动力学，分布半衰期为30分钟，终末半衰期为135分钟。血浆峰值浓度为14.7μg/ mL，清除率为201.9mL /（min * kg）。总体而言，从 L中鉴定出了几种新化合物。与NDGA相比，tridentata 对人癌细胞的治疗指数更高。这种生长抑制可能涉及拓扑异构酶II抑制，从而导致细胞周期停滞和DNA合成受损。

著录项

  • 作者

    Lambert, Joshua David.;

  • 作者单位

    The University of Arizona.;

  • 授予单位 The University of Arizona.;
  • 学科 Health Sciences Pharmacology.; Chemistry Organic.
  • 学位 Ph.D.
  • 年度 2001
  • 页码 132 p.
  • 总页数 132
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 药理学;有机化学;
  • 关键词

  • 入库时间 2022-08-17 11:47:19

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号